ADC Therapeutics.
company in Épalinges, Switzerland
- Reports this week
- 0
- Active events
- 0
- Connections
- 16
What's happening
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around ADC Therapeutics this week
News at the entities that move ADC Therapeutics most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves ADC Therapeutics
-
European Commission StructuralA European Commission summit focused on strategic cooperation, minerals, and pivoting away from the United States toward the EU.Moves ADC Therapeutics
-
New Jersey Shared contextA pilot program is launching in New Jersey, involving investments and legislation, with Mikie Sherrill and SPARK involved.Moves ADC Therapeutics
-
Nasdaq Shared contextApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves ADC Therapeutics
-
London Shared contextHelen Flanagan is leading a suspected state-threat investigation through Counter Terrorism Policing in London.Moves ADC Therapeutics
-
Switzerland Shared contextECB has established swap line arrangements with central banks, with the ECB President leading central bank operations.Moves ADC Therapeutics
Connections
The 12 strongest of 16, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
ADC Therapeutics' drug development and commercial status are fundamentally governed by regulatory actions and approvals from the FDA.
-
Mohamed Zaki Structural
Mohamed Zaki serves as the Chief Medical Officer for ADC Therapeutics.
-
European Commission Structural
ADC Therapeutics received conditional approval for ZYNLONTA from the European Commission.
-
Lugano Shared context
ADC Therapeutics conducts research and presentations in Lugano, utilizing local criteria for response assessment.
-
New Jersey Shared context
ADC Therapeutics conducts business operations within the geographical boundaries of New Jersey.
-
Nxera Pharma Operational
The companies are actively competing in the market, as evidenced by direct comparisons of their financial and market performance.
-
Nasdaq Shared context
ADC Therapeutics is listed and trades on the Nasdaq market platform.
-
London Shared context
ADC Therapeutics maintains operational presence within London.
Show all 12 connections
-
Lausanne Shared context
ADC Therapeutics is headquartered in Lausanne, Switzerland.
-
Switzerland Shared context
ADC Therapeutics is a company based and operating within Switzerland.
-
Milan Shared context
ADC Therapeutics conducts clinical trials and presents data within Milan.
-
Italy Shared context
ADC Therapeutics conducts clinical trials and presents data within Italy.